Three Scientists Win John Scott Award in Philadelphia
The American Philosophical Society honors regional experts for contributions to human understanding and drug discovery.
Updated on Oct. 27, 2026 in Science — General
Live Poll
Should scientific awards prioritize researchers who work in the local region?
The American Philosophical Society awarded the John Scott Award to Nina Jablonski, Magid Abou-Gharbia, and Daniel Skovronsky. Each recipient received a $10,000 prize in recognition of their contributions to human understanding and drug discovery.
Why it matters
The awards highlight regional leadership in pharmaceutical innovation and anthropological research. By prioritizing Pennsylvania-linked scientists, the society emphasizes the role of local academic and industry hubs in advancing global health and scientific inquiry.
Magid Abou-Gharbia holds 145 U.S. patents and has been involved in the discovery of 10 marketed drugs. His work at the Moulder Center has generated $30 million in research funding.
The players
Magid Abou-Gharbia
A Temple University professor and prolific inventor who holds 145 U.S. patents.
Daniel Skovronsky
An executive at Eli Lilly and founder of Avid Radiopharmaceuticals.
Nina Jablonski
A professor at Penn State University recognized for her contributions to human understanding.
American Philosophical Society
A long-standing institution that presents the John Scott Award to scientists in the Pennsylvania region.
The details
The advisory committee selects honorees based on their impact on human welfare and happiness, focusing on breakthroughs in science. Magid Abou-Gharbia, a Temple University professor, moved to Philadelphia for his PhD in 1974 and later returned to academia in 2008. Daniel Skovronsky, an Eli Lilly executive, founded Avid Radiopharmaceuticals, which developed Amyvid, a diagnostic tool for identifying Alzheimer's disease brain plaques that received FDA approval.
Timeline
1974: Magid Abou-Gharbia moved to Philadelphia for his doctoral studies.
2008: Magid Abou-Gharbia transitioned back into an academic career.
2010: Eli Lilly acquired Avid Radiopharmaceuticals.
October 2026: The American Philosophical Society presented the awards.
The Tech Race
The awards highlight the ongoing competition to translate basic scientific research into clinically viable diagnostics and therapies. This reinforces the focus on regional hubs, such as Philadelphia, in maintaining a high density of patent output and pharmaceutical development.
The innovations recognized here, such as Alzheimer's diagnostic tools, directly influence clinical workflows for medical providers and patient diagnostic timelines. Local researchers and industry professionals can look to these winners as indicators of current priorities in regional biotech development.
The takeaway
The selection underscores the importance of institutional recognition in validating drug discovery pathways that originate in university laboratories. Interested parties can monitor future award announcements from the American Philosophical Society to track which local scientific advancements gain industrial adoption.
Further reading
Learn more about the region's broader academic output in Science — General.
Source note: This article includes information reported by The Philadelphia Inquirer.
Live Poll
Should scientific awards prioritize researchers who work in the local region?
